← Eichor
Study identifier: NCT06906627 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Condition: Chronic Kidney Disease(CKD) · Type 2 DM · Type 2 Diabetes Mellitus (T2DM)  ·  Sponsor: Duke University

PhaseNA
Planned participants750
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

This description comes directly from the study's public registry record.

Talk to the study team

Gretchen Sanders, MSN  ·  919 6687829  ·  gretchen.sanders@duke.edu

Monica Leyva, MS  ·  monica.leyva@duke.edu

Always discuss trial participation with your own doctor first.

Locations (7)

University of AlabamaBirmingham, Alabama, United StatesRecruiting
Orlando HealthSt. Petersburg, Florida, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Essentia HealthDuluth, Minnesota, United StatesRecruiting
Duke UniversityDurham, North Carolina, United StatesRecruiting
Houston MethodistHouston, North Carolina, United StatesRecruiting
Baylor Scott & WhiteTemple, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06906627